Latest Angina pectoris Stories
-- Data Presented at the American College of Cardiology 2010 Annual Meeting Suggests Treatment with the Neovasc Reducer Is Safe and Improves Angina Symptoms for at Least Three Years -- TSX Venture Exchange: NVC VANCOUVER and ATLANTA, March 16 /PRNewswire-FirstCall/ - Neovasc Inc.
Two studies published in the latest issue of Cell Transplantation (18:12) may lead to new treatments for the treatment of heart diseases.
American Journal of Cardiology paper sheds light on heart attack symptoms DALLAS, Dec.
Transplanting peopleâ€™s own stem cells into heart lessens pain, improves ability to walk.
Mild exercise can significantly reduce the risk of early death from heart disease, according to a new study published in the American Journal of Medicine.
The world's largest quality of life study of chronic angina patients attending general practice clinics has revealed that almost one in three experience frequent chest pain, which affects their daily life.
The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved cardiovascular outcome in Japanese hypertensive patients at high risk of CVD events.
Women may have a slightly higher risk of death than men in the 30 days following an acute coronary syndrome (ACS) such as heart attack or unstable angina, according to a new study.
- Growing in low tufty patches.